Bellicum Pharmaceuticals Inc. buy krebskrebs
Start price
07.02.22
/
50%
€1.24
Target price
07.02.23
€2.00
Performance (%)
-1.61%
End price
08.02.23
€1.22
Summary
This prediction ended on 08.02.23 with a price of €1.22. With a performance of -1.61%, the BUY prediction by krebskrebs finished with a loss. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bellicum Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
Comments by krebskrebs for this prediction
In the thread Bellicum Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Bellicum Pharmaceuticals Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten